about
Translational Research and Functional Changes in Voiding Function in Older AdultsUrodynamic investigation by telemetry in Beagle dogs: validation and effects of oral administration of current urological drugs: a pilot study.Investigation of early protein changes in the urinary bladder following partial bladder outlet obstruction by proteomic approach.Alterations of the myovesical plexus of the human overactive detrusor.Changes in nocturia after photoselective vaporization of the prostate for patients with benign prostatic hyperplasiaTreatment satisfaction after 1 year high-power potassium-titanyl-phosphate photoselective vaporization of the prostate.Effects of bladder outlet obstruction on properties of Ca2+-activated K+ channels in rat bladderDietary macronutrient and energy intake and urinary incontinence in women.Detrusor overactivity is associated with downregulation of large-conductance calcium- and voltage-activated potassium channel protein.Phosphodiesterase type 9 (PDE9) in the human lower urinary tract: an immunohistochemical study.Association between Lower Urinary Tract Symptoms and Vascular Risk Factors in Aging Men: The Hallym Aging Study.Obstruction-induced alterations within the urinary bladder and their role in the pathophysiology of lower urinary tract symptomatology.120 W Greenlight HPS Laser Photoselective Vaporization of the Prostate for Treatment of Benign Prostatic Hyperplasia in Men with Detrusor Underactivity.Medical management of overactive bladderBiomechanical properties and innervation of the female caveolin-1-deficient detrusor.Molecular mechanisms of bladder outlet obstruction in transgenic male mice overexpressing aromatase (Cyp19a1).Dietary macronutrient intake and lower urinary tract symptoms in women.Prospective pharmacologic therapies for the overactive bladderOveractive bladder in malesSolifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasiaExpression of brain derived-neurotrophic factor and granulocyte-colony stimulating factor in the urothelium: relation with voiding function.Detrusor expulsive strength is preserved, but responsiveness to bladder filling and urinary sensitivity is diminished in the aging mouseAssociation of lower urinary tract syndrome with peripheral arterial occlusive disease.Update on the management of overactive bladder: patient considerations and adherenceThe link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction.Incidence and risk factors of recurrence of overactive bladder symptoms after discontinuation of successful medical treatment.Impact of partial urethral obstruction on bladder function: time-dependent changes and functional correlates of altered expression of Ca²⁺ signaling regulators.Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action.Urethral lift for benign prostatic hyperplasia: a comprehensive review of the literature.Functional consequences of chronic bladder ischemia.Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to vascular dysfunction?Finasteride monotherapy maintains stable lower urinary tract symptoms in men with benign prostatic hyperplasia following cessation of alpha blockers.Persistent detrusor overactivity in rats after relief of partial urethral obstruction.Importance of prostate volume and urinary flow rate in prediction of bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia.Urodynamic findings in women with refractory overactive bladder symptoms.Beta adrenergic modulation of spontaneous microcontractions and electrical field-stimulated contractions in isolated strips of rat urinary bladder from normal animals and animals with partial bladder outflow obstruction.Changes in Awake Cystometry and Expression of Bladder β-adrenoceptors after Partial Bladder Outlet Obstruction in Male Rats.Protein kinase C activation of a blebbistatin sensitive contractile component in the wall of hypertrophying mouse urinary bladder.5-Hydroxytryptamine-induced bladder hyperactivity via the 5-HT2A receptor in partial bladder outlet obstruction in rats.Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III).
P2860
Q26782134-5BC74D95-8CA6-41FA-915F-270C3917A193Q31141218-5446B899-3F4E-4999-AE2A-8C845BBE8D9AQ33229810-F098A3AA-2CAF-4DE4-9DFA-05FA08FA1DB1Q33562585-7FA6DCB2-F209-45E5-ADE2-25303431FAD2Q33670768-9F05D923-4722-4F65-B348-62E8D28C457AQ33684775-8711ED4A-6E78-4779-882D-8CED131FEDCDQ33841023-F3297475-B9E1-4F05-BDD4-BECAB79B7698Q33880849-FB00546A-E157-41C1-B3AF-46C3E25C32B5Q33917816-7B50E8BD-E634-4781-85DE-CBDA2673359AQ33953840-39F011D7-A47C-4379-8278-5B194CAD8DB1Q34009467-28AF1528-8B36-489C-AA5C-71066316DB52Q34062449-019609BE-1BC3-4460-9206-B8F9BBF1B33CQ34117977-0448260D-AA63-4BDC-833A-744E7CEA2933Q34124065-4E008364-62DE-4515-BA13-2B0CE6B76F69Q34636273-20316DF4-AD6C-4C3E-B6A3-9DE39C38F2A9Q34760746-4638B6C5-86C0-427C-8F67-C8C76C94F7C7Q34959268-36B17DC0-305B-4184-99E5-55530A53003DQ35076367-E744565B-51DD-4364-A309-A420E2767644Q35076391-AD8BA33C-840D-482A-BAA4-2C16AF8FB92EQ35212816-69D6EF60-7BFF-4DDE-885E-C17D5893817EQ35620417-B3CEF004-686B-47B0-90A1-4941F013C062Q35850291-6E41023A-753E-459B-BAD9-6E672629F0E3Q36310565-1EAD9F95-B684-4113-8F87-D2F2B254497DQ37283704-A8A66B6E-C796-406B-905D-BDEC0FA8146FQ37514602-7BE9DE9C-BAF2-4D9B-8ED4-90A62348F3F0Q37589167-4D94E62C-6006-46D8-A4BF-4A251D3CE263Q37655877-520F4CE4-699E-4209-BD0B-5A77270AE487Q37833959-BF64F360-1475-4797-9BE2-BD9BF926772BQ38116465-8898D16F-AE04-4EB7-BB98-2C5857AA462BQ38167664-22BF81CF-D2DD-44FD-B19B-BF44736D13D7Q38220350-115301AA-188C-4B95-9609-155B9D6374DCQ39020100-32F0233A-8DD9-44A4-A440-E779BAA46E63Q39261903-AFE0DDE8-37E0-40F8-ACEA-3E1B89A35310Q40174118-848F94CD-99C3-490F-BBE2-187301F360EAQ40487583-9DEBCD70-F201-4C52-BEB2-E2911E4D187EQ40865070-E4D52FAB-0EE1-40CE-A8EC-F94CEEC33A4CQ41161533-8BD047E3-4DE4-4403-992C-C18B526AA6B9Q41187705-5D850FC3-B0AE-46D3-A5C7-6855C2B6B7FBQ44759182-0F1B3F0F-FB35-4926-A550-44A36D63493FQ45239207-625A35CF-AA51-4662-B0F4-B56A9CF66E80
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Storage and voiding symptoms: pathophysiologic aspects.
@ast
Storage and voiding symptoms: pathophysiologic aspects.
@en
type
label
Storage and voiding symptoms: pathophysiologic aspects.
@ast
Storage and voiding symptoms: pathophysiologic aspects.
@en
prefLabel
Storage and voiding symptoms: pathophysiologic aspects.
@ast
Storage and voiding symptoms: pathophysiologic aspects.
@en
P1433
P1476
Storage and voiding symptoms: pathophysiologic aspects.
@en
P2093
Karl Erik Andersson
P356
10.1016/J.UROLOGY.2003.09.030
P407
P433
P577
2003-11-01T00:00:00Z